Oral Oncology

Papers
(The H4-Index of Oral Oncology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Rare mandibular metastasis of Ewing sarcoma presenting as an endodontic infection86
Comment on “Circulating miRNAs as diagnostic biomarkers in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC)”65
Commentary on, “Optimization of methylation capture sequencing workflow in formalin fixed tissue from oral squamous cell carcinoma patients”62
Commentary on, “Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid carcinoma: Surgical and oncological outcomes.”56
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”43
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma40
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis40
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma36
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review35
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study34
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?34
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD)33
Squamous odontogenic tumor like proliferations in dentigerous cyst- a great mimicker33
Editorial Board/Aims & Scope32
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model32
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection32
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study31
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies30
P28 Head and neck cancer cells differentiate resembling their tissue of origin30
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]30
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment29
Corrigendum to “Epigenetics: Promising journey so far but ways to go in head neck cancer” [Oral Oncol. 135 (2022) 106194]29
Myxoid variant of extramammary myofibroblastoma affecting the buccal mucosa: An extremely rare oral lesion and literature review29
Illustrating potential actionable drug targets of head and neck tumors based on comprehensive genomic landscape of 386 samples28
Radiation-induced sarcomas of the craniofacial region: A systematic review27
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharynge27
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis26
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”26
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”26
0.67441916465759